Clinical Trial Update: The ONE Study nTreg Trial (ONEnTreg13) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update for theONE Study nTreg trial (ONEnTreg13) in living-donor renal transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Living-donor Kidney Transplantation
• Renal Transplantation

Snippet

Sponsor: Prof. Dr. Petra Reinke | Conditions: Immunosuppressive Treatment of Living-donor Renal Transplantation | Phase 1, Phase 2 | Status: COMPLETED